Patents by Inventor Ernesto López-Pascual

Ernesto López-Pascual has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for inhibiting mesenchymal phenotype after epithelial-to-mesenchymal transition
    Publication number: 20160184274
    Abstract: Methods of using inhibitors of Goodpasture Antigen Binding Protein for inhibiting mesenchymal phenotype after epithelial-to-mesenchymal transition (EMT), treating an invasive tumor, and detecting EMT in a tissue are described.
    Type: Application
    Filed: December 30, 2015
    Publication date: June 30, 2016
    Inventors: Juan Saus, Fernando Revert, Aida Artigot, Francisco Revert-Ros, Ernesto Lopez-Pascual, Raul Blasco, Nuria Roda, Juan F. Sanz-Cervera, Roberto Gozalbo-Rovira
  • GPBP-1 inhibition and its therapeutic use
    Publication number: 20150320730
    Abstract: The present invention provides compositions including anti-tumor agents and inhibitors of Goodpasture antigen binding protein, p21, and ABCC7, and their use in treating cancer.
    Type: Application
    Filed: June 17, 2015
    Publication date: November 12, 2015
    Inventors: Juan Saus, Francisco Ravert-Ros, Fernando Revert, Carmen Aguado-Velasco, Ernesto Lopez-Pascual, Alejandra Maria Perez-Sastre, Raúl Blasco, Héctor Pérez-Montoyo
  • GPBP-1 inhibition and its therapeutic use
    Patent number: 9066938
    Abstract: The present invention provides compositions including anti-tumor agents and inhibitors of Goodpasture antigen binding protein, p21, and ABCC7, and their use in treating cancer.
    Type: Grant
    Filed: July 2, 2013
    Date of Patent: June 30, 2015
    Assignees: Fibrostein, S.L., Universitat de Valencia
    Inventors: Juan Saus, Francisco Revert-Ros, Fernando Revert, Carmen Aguado-Velasco, Ernesto López-Pascual, Alejandra María Pérez-Sastre, Raúl Blasco, Héctor Pérez-Montoyo
  • GPBP-1 inhibition and its therapeutic use
    Publication number: 20140005134
    Abstract: The present invention provides compositions including anti-tumor agents and inhibitors of Goodpasture antigen binding protein, p21, and ABCC7, and their use in treating cancer.
    Type: Application
    Filed: July 2, 2013
    Publication date: January 2, 2014
    Inventors: Juan Saus, Francisco Revert-Ros, Fernando Revert, Carmen Aguado-Velasco, Ernesto López-Pascual, Alejandra Maria Pérez-Sastre, Raúl Blasco, Héctor Pérez-Montoyo